Carcinoma of the Oropharynx
3 clinical trials · Condition
◉ Watch Carcinoma of the Oropharynx
| Record | Firm | Date |
|---|---|---|
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs (NCT04985357) | Travera Inc | 2024-11-01 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx (NCT01140178) | Roswell Park Cancer Institute | 2010-06-08 |
Track Carcinoma of the Oropharynx automatically
Every clearance here is in the API, with alerts when new ones post.